{"title":"衣原体药敏试验问题","authors":"MD Charles W. Stratton","doi":"10.1016/S1069-417X(00)80015-1","DOIUrl":null,"url":null,"abstract":"<div><p>It becomes painfully clear that there are a number of critical issues that must be addressed if susceptibility testing of chlamydiae is going to be regarded in the same light as that for other microorganisms. The NCCLS should be encouraged to institute a subcommittee to study this problem as has been done with other areas of susceptibility testing. It is through this consensus mechanism that uniformity of testing, if not clinical relevance will be achieved.</p></div>","PeriodicalId":100102,"journal":{"name":"Antimicrobics and Infectious Diseases Newsletter","volume":"16 2","pages":"Pages 14-16"},"PeriodicalIF":0.0000,"publicationDate":"1997-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1069-417X(00)80015-1","citationCount":"0","resultStr":"{\"title\":\"Issues for chlamydial susceptibility testing\",\"authors\":\"MD Charles W. Stratton\",\"doi\":\"10.1016/S1069-417X(00)80015-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>It becomes painfully clear that there are a number of critical issues that must be addressed if susceptibility testing of chlamydiae is going to be regarded in the same light as that for other microorganisms. The NCCLS should be encouraged to institute a subcommittee to study this problem as has been done with other areas of susceptibility testing. It is through this consensus mechanism that uniformity of testing, if not clinical relevance will be achieved.</p></div>\",\"PeriodicalId\":100102,\"journal\":{\"name\":\"Antimicrobics and Infectious Diseases Newsletter\",\"volume\":\"16 2\",\"pages\":\"Pages 14-16\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1997-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1069-417X(00)80015-1\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antimicrobics and Infectious Diseases Newsletter\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1069417X00800151\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobics and Infectious Diseases Newsletter","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1069417X00800151","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
It becomes painfully clear that there are a number of critical issues that must be addressed if susceptibility testing of chlamydiae is going to be regarded in the same light as that for other microorganisms. The NCCLS should be encouraged to institute a subcommittee to study this problem as has been done with other areas of susceptibility testing. It is through this consensus mechanism that uniformity of testing, if not clinical relevance will be achieved.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
